BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, June 7, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 11, 2015
View Archived Issues
AstraZeneca reflects on achievements of fourth quarter 2014
Read More
bioCSL to sell ALK allergy products in Australia and New Zealand
Read More
GlaxoSmithKline presents milestones of fourth quarter 2014
Read More
Trevena reports data from phase I study of TRV-734 for acute and chronic pain
Read More
Preclinical data suggest utility of ANAVEX 2-73 for epilepsy
Read More
Aurinia plans pilot biomarker study of voclosporin in lupus nephritis
Read More
Inflection Biosciences and Multiple Myeloma Research Foundation collaborate on IBL-202
Read More
Aduro Biotech initiates IND-enabling studies and achieves milestone in Janssen collaboration
Read More
Takeda reflects on accomplishments of third quarter of fiscal 2014
Read More
SGX-943 shows promising results for melioidosis
Read More
AB Science provides update on futility test for masitinib in Alzheimer's disease
Read More
Anthera Pharmaceuticals reports on interim analysis from blisibimod trial in SLE
Read More
NDA filed for ibandronate sodium hydrate in Japan
Read More
Shanghai Fochon Pharmaceutical patents EFGR/HER2 inhibitors for cancer
Read More
Chinese companies develop paliperidone amino acid derivatives
Read More
Novartis reports autotaxin inhibitors
Read More
Epizyme patent divulges EZH2 inhibitors
Read More
Otsuka Pharmaceutical patents citric acid cycle activators
Read More
Solithromycin protects against tularemia in non-human primate model
Read More
FDA expands clearance for Nanotherapeutics bone filler to use in spinal fusion surgery
Read More
Cellular Biomedicine Group acquires CAR-T therapy and IP from Chinese PLA General Hospital
Read More
FDA approves MediciNova's protocol for phase II trial of tipelukast in IPF
Read More
New phase IIa study investigates FRM-0334 for frontotemporal dementia with GRN mutation
Read More
Pfenex and Hospira to collaborate on Lucentis biosimilar
Read More
JCR begins clinical study of biosimilar for Fabry's disease
Read More
